Evidence map›Paper›PMID 35486691›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Phenotypic determinism and stochasticity in antibody repertoires of clonally expanded plasma cells.

Daniel Neumeier, Alexander Yermanos, Andreas Agrafiotis, Lucia Csepregi, Tasnia Chowdhury, Roy A Ehling, Raphael Kuhn, Tudor-Stefan Cotet, Raphaël Brisset-Di Roberto, Mariangela Di Tacchio and 5 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Daniel NeumeierDepartment of Biosystems Science and Engineering, ETH Zürich, 4058 Basel, Switzerland.
Alexander YermanosDepartment of Biosystems Science and Engineering, ETH Zürich, 4058 Basel, Switzerland.
Andreas AgrafiotisDepartment of Biosystems Science and Engineering, ETH Zürich, 4058 Basel, Switzerland.
Lucia CsepregiDepartment of Biosystems Science and Engineering, ETH Zürich, 4058 Basel, Switzerland.ORCID 0000-0002-0709-4244
Tasnia ChowdhuryUCB Pharma, Slough SL1 3WE, United Kingdom.
Roy A EhlingDepartment of Biosystems Science and Engineering, ETH Zürich, 4058 Basel, Switzerland.ORCID 0000-0002-4879-8168
Raphael KuhnDepartment of Biosystems Science and Engineering, ETH Zürich, 4058 Basel, Switzerland.
Tudor-Stefan CotetDepartment of Biosystems Science and Engineering, ETH Zürich, 4058 Basel, Switzerland.ORCID 0000-0002-7701-6225
Raphaël Brisset-Di RobertoDepartment of Biosystems Science and Engineering, ETH Zürich, 4058 Basel, Switzerland.ORCID 0000-0003-0976-5395
Mariangela Di TacchioDepartment of Biosystems Science and Engineering, ETH Zürich, 4058 Basel, Switzerland.
Renan AntonialliDepartment of Biosystems Science and Engineering, ETH Zürich, 4058 Basel, Switzerland.
Dale StarkieUCB Pharma, Slough SL1 3WE, United Kingdom.
Daniel J LightwoodUCB Pharma, Slough SL1 3WE, United Kingdom.
Annette OxeniusInstitute of Microbiology, ETH Zürich, 8093 Zurich, Switzerland.
Sai T ReddyDepartment of Biosystems Science and Engineering, ETH Zürich, 4058 Basel, Switzerland.ORCID 0000-0002-9177-0857
ETH Zurich · CHUCB Pharma (United Kingdom) · GBUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The capacity of humoral B cell-mediated immunity to effectively respond to and protect against pathogenic infections is largely driven by the presence of a diverse repertoire of polyclonal antibodies in the serum, which are produced by plasma cells (PCs). Recent studies have started to reveal the balance between deterministic mechanisms and stochasticity of antibody repertoires on a genotypic level (i.e., clonal diversity, somatic hypermutation, and germline gene usage). However, it remains unclear if clonal selection and expansion of PCs follow any deterministic rules or are stochastic with regards to phenotypic antibody properties (i.e., antigen-binding, affinity, and epitope specificity). Here, we report on the in-depth genotypic and phenotypic characterization of clonally expanded PC antibody repertoires following protein immunization. We find that clonal expansion drives antigen specificity of the most expanded clones (top ∼10), whereas among the rest of the clonal repertoire antigen specificity is stochastic. Furthermore, we report both on a polyclonal repertoire and clonal lineage level that antibody-antigen binding affinity does not correlate with clonal expansion or somatic hypermutation. Last, we provide evidence for convergence toward targeting dominant epitopes despite clonal sequence diversity among the most expanded clones. Our results highlight the extent to which clonal expansion can be ascribed to antigen binding, affinity, and epitope specificity, and they have implications for the assessment of effective vaccines.

Indexed as

AntigensPlasma CellsAnimalsAntibodiesAntibody AffinityEpitopesMiceAntibodiesAntigensEpitopesantibodyepitoperepertoiresequencingspecificity

Identifiers

PMID35486691
PMCPMC9170022
OpenAlexW4225246898

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.